medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

1999, Number 4

<< Back Next >>

Rev ADM 1999; 56 (4)

Pharmacological management of the pregnant patient in dentistry

Gómez CJF,Calleja QE

Language: Spanish
References: 19
Page: 158-162
PDF size: 112.50 Kb.


ABSTRACT

This paper reviews issues related with drug administration in pregnancy. Pharmacological products that are considered safe drugs in pregnancy by FDA (Food And Drugs Administration) and European Community (Committee of Propietary Medicinal Products) which are useful in dental practice are included.


REFERENCES

  1. Briggs GG, Freenan RK, Yaffe SJ . A reference guide to fetal and neonatal risk. Drugs in pregnancy and lactation. 4a. ed. Williams & Wilkins Galt, 1994.

  2. Byer AJ, Taylor TR, Semmer JR. Acetaminophen overdose in third trimester of pregnancy. JAMA 1982; 247: 3114-3115.

  3. European Community. Proposal categorization of medicinal products in pregnancy for the Committee of Propietary Medicinal Products. European Community, 1991.

  4. Fiese R, Herzog S. Issues in dental and surgical management of the pregnant patient. Oral Surg Oral Med Oral Pathol 1988; 65: 292-297.

  5. Forfar J, Nelson M. Epidemiology of drugs taken by pregnant women: drugs that may affect the fetus adversely. Clin Pharmacol Ther 1973; 14: 632.

  6. Goldberg JD, Golbus M. The value of case reports in human teratology. Am J Obstet Gynecol 1986; 154: 479-482.

  7. Gómez Clavel JF, Verdin Terán SL. Uso racional de anestésicos locales en el embarazo. Práctica Odontológica 1994; 15 (11): 9-11.

  8. Haibach H, Akhter JE, Muscato MS, Cary PL, Hoffman MF. Acetaminophen overdose with fetal demise. Am J Clin Pathol 1984; 82: 240-242.

  9. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group, 1977.

  10. Hedstrom S, Martens MG. Antibióticos durante el embarazo. Infecciones durante el embarazo. Clínicas obstétricas y ginecológicas. Vol. 4. México: Interamericana 1994: 835-840.

  11. Koren G, Bologa M, Long D, Feldman Y, Henderson K, Shear N. The perception of teratogenic risk during the first trimester of pregnancy. Am J Obstet Gynecol 1989; 160: 1190-1194.

  12. Koren G. A quality assurance program for teratogen information services. Reproductive Toxicology 1992; 6: 293-295.

  13. Manson JM, Zolna LE, Kang YJ et al. Effects of cefonocid and other cephalosporin antibiotics on male sexual development in rats. Antimicrob Agents Chemother 1987: 31(7).

  14. McCormack WM, George H, Donner A, Kodgis LF, Albert S, Lowe EW, Kass EH. Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother 1977; 12: 630-635.

  15. Peters PWJ, Garbis-Berkvens HM, Bannigan JG. Drugs of choise in pregnancy: primary prevention of birth defects. Reproductive Toxicology 1993; 7: 399-404.

  16. Philipson A. Pharmacokinetics of ampicillin during pregnancy. J Infect Dis 1977; 136: 370-376.

  17. Rollins DE, Von Bahr C, Glaumann H, Moldens P, Rane H. Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science 1979; 205: 1414-1416.

  18. Stokes IM. Paracetamol overdose in the second trimester of pregnancy. Case report. Br J Obstet Gynaecol 1984; 67: 286-288.

  19. UNICEF 1992: Drug use in pregnancy. The prescriber, Jan 1992.




2020     |     www.medigraphic.com